In this episode, host Shikha Jain, MD, speaks with Jorge García, PharmD, about the economic benefits of biosimilars, the unique perspective pharmacists can bring to cancer care costs and more.

•    Welcome to another exciting episode of Oncology Overdrive :14
•    About García :23
•    The interview 2:44
•    How did you enter the world of pharmacy? What was your journey into this field? 3:11
•    Can you tell us about what biosimilars are, and how you found yourself in this space?  5:09
•    What do you think is the next step for biosimilars? 6:34
•    What types of diseases specifically are biosimilars the most exciting for? … What are diseases that biosimilars have the highest impact in? 8:09
•    What is Act4Biosimilars, and what do they do? 12:05
•    How did you get involved with Act4Biosimilars?  13:04 
•    Can you expand on what Act4Biosimilars is doing to address inequities and disparities in health care? Is there a way to get biosimilars into the hands of more people who really need it? 14:55
•    How do you see the impact of these initiatives and interventions are going to be over the next few years? 17:14
•    How do you suggest people who are interested in getting involved in this type of work find this path? 19:31 
•    Jain and García on his unique perspective of being a pharmacist and having an MBA and understanding cost of care 24:22 
•    If you had a crystal ball, and you could see five or ten years from now, what do you hope will have changed in the biosimilar news space? 27:13 
•    If someone could only listen to the two minutes of this episode, what would you want them to take away? 30:36
•    How to contact García 31:27
•    Thanks for listening 32:32

Jorge García, PharmD, MS, MHA, MBA, FACHE is the assistant vice president at Baptist Health South Florida, where he is responsible for oncology pharmacy services, non-oncology infusion pharmacy services, and sterile compounding quality.

We’d love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow us on Twitter @HemOncToday and @ShikhaJainMD. García can be reached via LinkedIn.

Disclosures: García and Jain report no relevant financial disclosures.